On June 16, 2023, the United States Supreme Court issued an 8-1 decision in the case of United States, ex rel. Polansky v. Executive Health Resources, Inc., which held that the Department of Justice (DOJ) can move to dismiss...more
6/21/2023
/ Article II ,
Constitutional Challenges ,
Department of Justice (DOJ) ,
False Claims Act (FCA) ,
Federal Rules of Civil Procedure ,
Healthcare Fraud ,
Judicial Intervention ,
Lack of Authority ,
Motion to Dismiss ,
Qui Tam ,
Regulatory Authority ,
Relators ,
SCOTUS ,
United States ex rel Polansky v Executive Health Resources Inc ,
Whistleblowers
In recent years, the U.S. Department of Justice (DOJ) has been criticized for failing to prosecute executives for fraud, particularly in the financial sector. In response, the DOJ has begun to more heavily emphasize...more
6/29/2015
/ Ambulance Providers ,
CEOs ,
Department of Justice (DOJ) ,
Durable Medical Equipment ,
Enforcement ,
Enforcement Actions ,
Fraud ,
Healthcare Fraud ,
Home Health Agencies ,
Hospitals ,
Medicare ,
Personal Liability ,
Pharmaceutical Industry ,
Pharmacies ,
White Collar Crimes
Last summer, a federal judge in Houston ruled that the Wartime Suspension of Limitations Act (WSLA), found in Title 18, ยง 3287 of the U.S. Criminal Code, applied to a civil False Claims Act (FCA) case and suspended the...more
Last week, the U.S. Department of Health and Human Services (HHS) and the DOJ jointly released a report concluding that, for every dollar spent on healthcare fraud investigations in the last three years, the government...more